Toward bioprinting industrialization – Presented by Fabien Guillemot, Poietis

Toward bioprinting industrialization – Presented by Fabien Guillemot, Poietis at the 3D Medical Conference, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

Bioprinting has been defined as “the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies”.

From a technological point of view, different bioprinting technologies have been developed so far. Recently, Laser-Assisted Bioprinting (LAB) technology has emerged as an alternative method to inkjet and bioextrusion methods, thereby overcoming some of their limitations (namely clogging of print heads or capillaries) to pattern living cells and biomaterials with a micron-scale resolution and high cell viability.

During this presentation, we will present current development on the industrialization of bioprinting process, namely in the context of manufacturing 3D skin models.

About Fabien Guillemot
Dr Fabien Guillemot has an over 20 years experience in the field of Regenerative Medicine. He holds a PhD in Material Science from the National Institute of Applied Sciences Rennes (2000) and an Habilitation in Health and Life Sciences from Bordeaux University (2010).

Fabien was appointed Researcher at INSERM in 2005 and was also Invited Researcher at Harvard University in 2010. He initiated pioneering work in the field of bioprinting and has published over 20 scientific articles and more than 100 invited lectures on this new technology.

Before founding Poietis company, he also completed its scientific training by an entrepreneurship program provided at HEC, Paris.

About Poietis 
Poietis is a biotechnology company specializing in the laser-assisted bioprinting of living tissue. It provides industrial stakeholders and researchers with a unique platform to design and manufacture bio-printed products for regenerative medicine, preclinical research and evaluating the efficacy of cosmetic products and ingredients. The unquestionable added value of the Poietis platform is its ability to design and manufacture tissue with cellular resolution. This allows very precise control of the manufacturing process and guarantees the reproducibility and reliability of bio-printed products.

3D Medical Printing ConferenceAbout 3D Medical Conference
On January 30-31, 2018, MECC Maastricht, The Netherlands, will host a two-day event focused on 3D Medical Printing. Each day has different topics.

Day 1, Jan 30:

Day 2, Jan 31:

The audience, a mix of academics, medical professionals, business, technology, regulation and creatives, will get an excellent overview and insight in the medical tech developments from different perspectives.

Combination tickets are available and can be purchased on any of the conference websites

Leave a Reply

Your email address will not be published. Required fields are marked *